Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    PR Mobile Headlines    |    Today's News    |    News By Category    |    News By Region    |    News By Date    |    Business Directory    |    Private Branding
All Press Releases for December 04, 2008 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



SIGVARIS Advances Compression Therapy and Venous Disease Management Knowledge with STEP UP Educational Program
SIGVARIS North America has developed the STEP UP educational program to help medical product retailers and health professionals advance their knowledge of compression therapy in the treatment of venous disease. 
x-small text small text medium text large text


    PEACHTREE CITY, GA, December 04, 2008 /24-7PressRelease/ -- SIGVARIS North America announced a new medical education program today that employs a unique twist to teach participants about venous disease, compression therapy and ways to better serve customers who are suffering from vein health issues.

STEP UP SIGVARIS is a knowledge-based competition that awards prizes to players who successfully answer a multiple-choice quiz after studying a three-part booklet that covers medical knowledge, product information and sales tactics.

"This is the first dealer education program of its kind in the US, and the aim of this innovative concept is to provide our retailers with useful information to help develop their compression therapy business," said Judith Brannan, Education Manager for SIGVARIS North America.

SIGVARIS offers the STEP UP program free of charge to all participants, with the goal of building awareness of compression therapy as a therapeutic treatment for venous disease and its' symptoms like spider veins, varicose veins and tired, achy legs.

The program aims to STEP UP a player's:
• knowledge of the venous system, related medical conditions and the positive benefits of compression therapy
• ability and enthusiasm for compression therapy sales, and
• capacity for recognizing patient needs to better serve them with appropriate products.

For more information on STEP UP SIGVARIS, please email sigvariscares@sigvaris.com or call 1.800.322.7744.

About SIGVARIS

SIGVARIS North America is part of an internationally active medical device group headquartered in Winterthur, Switzerland that focuses on the development, production and distribution of medical compression garments, including hosiery and socks. With distribution in more than 50 countries on six continents, SIGVARIS is recognized as a global industry leader in the area of compression therapy for the management of venous and lymphatic disorders. For more information, please visit http://www.sigvarisusa.com. SIGVARIS, LIFE FOR LEGS and the leg icon are registered trademarks of Ganzoni & Cie AG, St.Gallen/Switzerland and in many countries worldwide.

For more information, please contact:

Lisa Wells
SIGVARIS Marketing, North America
Email: lisa.wells@sigvaris.com
Phone: 770- 632-2962



Keywords: SIGVARIS, compression therapy, continuing education, medical device manufacturer, venous disease, varicose veins, spider veins, durable medical equipment dealers, educational program, medicine education, life for legs

# # #


Read more Press Releases from Lisa Wells:
Other Press Release Headlines:


Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Press Release Contact Information:
Lisa Wells
SIGVARIS

North America Product Manager
1119 Highway 74 S
Peachtree City, GA
USA 30269
Voice: 770-632-2962
Fax: 770-631-4883
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.